Clinical Innovations

What Clinical Innovations does

Clinical Innovations, founded in 1993 and headquartered in Murray, Utah, is a privately held medical device company that develops, manufactures, and markets specialized devices primarily serving obstetrics, neonatal care, and women's health markets. The company operates with 51–100 employees and has functioned as a subsidiary of Laborie Medical Technologies Corp.—a private Portsmouth, New Hampshire-based medical technology group—since Laborie's 2021 acquisition. The company's anchor product, the Kiwi vacuum-assisted delivery system, together with surrounding obstetric and neonatal devices, was the strategic rationale for Laborie's entry into the obstetrics segment. Clinical Innovations maintains an independent web presence at clinicalinnovations.com while its products are also surfaced under Laborie's broader maternal and child health portfolio.

Within Laborie's three-pillar platform spanning Urology & Urogynecology, Gastroenterology, and Maternal & Child Health, Clinical Innovations' obstetrics franchise sits adjacent to franchises built around regulated hardware: the Optilume drug-coated balloon catheter system for BPH and anterior urethral stricture, supported by three-year ROBUST III durability data; the NXT family of urodynamics systems; Macroplastique injectable bulking agent for stress urinary incontinence; the alpHaONE wireless pH capsule reflux monitoring system for GERD assessment; the Eclipse bowel control system for fecal incontinence; the ABBy postoperative panniculus retractor; and the LifeBubble umbilical catheter securement system. The technology base is mechanical, electromechanical, and polymer-pharmaceutically engineered—drug-coated balloons, wireless capsule telemetry, securement mechanics, suction-based hemorrhage control—rather than algorithmic. No APIs, AI/ML features, or digital health software products are documented in the source materials.

The business model is direct enterprise hardware sales: products are sold through field sales representatives to hospitals, clinics, and physician practices on quote-based terms that are not publicly disclosed, with revenue generated from therapeutic and diagnostic device sales plus associated consumables. Clinical adoption is supported by an extensive education infrastructure—117 upcoming webinars, 118 live training courses, 320 online course modules, and a co-development partnership with the International Continence Society for CME-accredited urodynamics content, with product-specific training delivered via the Litmos platform. Geographic reach extends across the United States, Europe (UK, France, Germany), Australia, and China through Laborie's six regional websites, and the group operates with a copyright line extending into 2026, indicating ongoing operations.

Name

Clinical Innovations

Legal name

Laborie Medical Technologies Corp.

Website

https://clinicalinnovations.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

51–100 employees

Short description

Clinical Innovations, founded 1993 in Murray, Utah, develops and markets specialized medical devices for obstetrics, neonatal care, and women's health; the company now operates as the maternal-health subsidiary of Laborie Medical Technologies following its 2021 acquisition.

Ownership category

akta.pro rank

Product category

Obstetric and Neonatal Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

Keywords

• Obstetric medical devices
• Maternal health devices
• Neonatal care products
• Vacuum-assisted delivery
• Gynecology instruments

Headquarters

HQ city

Murray

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Sales: Sale of medical devices and equipment to healthcare providers including hospitals, clinics, and physician practices. Revenue generated from therapeutic devices (Optilume catheters, JADA system, Eclipse system), diagnostic systems (NXT urodynamics, alpHaONE pH monitoring), and consumable/support products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Clinical Innovations develops, manufactures, and markets state-of-the-art medical devices focused on obstetrics, gynecology, and neonatal care. Its flagship product is the Kiwi vacuum-assisted delivery system. The company was acquired by Laborie Medical Technologies in 2021, after which its obstetrics portfolio (including the Kiwi system) was integrated into Laborie's broader Maternal & Child Health offering that also includes the JADA postpartum hemorrhage control system, ABBy postoperative panniculus retractor, and LifeBubble umbilical catheter securement system.

Product overview

Laborie Medical Technologies is a medical technology company offering a portfolio of diagnostic and therapeutic solutions across three main product categories: Urology & Urogynecology (including Optilume BPH Catheter System, Optilume Drug-Coated Balloon for urethral stricture, NXT Urodynamics Systems, Macroplastique, Urgent PC PTNS, and Eclipse for fecal incontinence), Gastroenterology (including alpHaONE Wireless pH Capsule, Renova Products, and Solar Compact System), and Maternal & Child Health (including JADA System for postpartum hemorrhage, ABBy Postoperative Panniculus Retractor, and LifeBubble Umbilical Catheter Securement). The company operates as a multi-product medical device portfolio serving pelvic and gastrointestinal conditions with both diagnostic equipment and therapeutic devices.

Differentiator

Problem solved

Functional benefit

Brands

• NXT Family: Family of urodynamics systems for urology and urogynecology diagnostics
• Optilume
• alpHaONE
• Renova
• Solar Compact
• JADA
• ABBy
• LifeBubble
• Eclipse
• Macroplastique
• Urgent PC

Products and services

• JADA System System for rapid postpartum hemorrhage control during childbirth, designed for obstetric use in labor and delivery units.
• ABBy Postoperative Panniculus Retractor

Quantifiable outcome

• Three-year data from ROBUST III study confirming long-term durability of Optilume Drug-Coated Balloon for recurrent urethral strictures

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Five partnerships are on record, tiered notable, core, supporting and strategic.

• Cleveland ClinicnotableStrategic or Co-development PartnerHoward B Goldman MD FACS from Cleveland Clinic has presented on Macroplastique best practices as part of Laborie's webinar education program. Collaboration involves clinical expertise sharing and professional education content development.
• Inova Women's HospitalnotableStrategic or Co-development PartnerS. Abbas Shobeiri, MD, MBA, FACS, FACOG, CMPE from Inova Women's Hospital has co-presented on Macroplastique treatment best practices as part of Laborie's clinical education programming.
• International Continence Society (ICS)coreStrategic or Co-development PartnerLaborie partners with ICS in developing new Urodynamic modules as part of its eLearning portfolio. The ICS e-Learning courses provide CME-accredited education from leading experts, with Laborie contributing to content development.
• LitmossupportingTechnology or IntegrationTraining management platform used for product-specific training courses including LifeBubble Training for Healthcare Professionals and ABBy Training for Healthcare Professionals. Courses include modules, video demonstrations, and post-assessments.
• OrganonstrategicStrategic or Co-development PartnerLaborie announced agreement to acquire the JADA System from Organon in November 2025, completing the acquisition in January 2026. JADA System is for rapid postpartum hemorrhage control, expanding Laborie's obstetrics portfolio.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Stryker Corporation: Stryker is a leading global medical device company with products across surgical, medical, and women's health. Broad incumbent with significant scale advantages in hospital contracting, salesforce coverage, and R&D investment relative to specialty peers.
• Hologic: Hologic is a large publicly-traded women's health medical technology company with diagnostics, surgical, and skeletal health products. Broad incumbent serving OB/GYN and women's health call points with greater scale and breadth than Clinical Innovations.
• Becton, Dickinson and Company (BD): BD is a diversified global medical technology company with products spanning women's health, obstetrics, surgical instruments, and medical disposables. Broad incumbent with scale advantages in hospital contracting and global distribution versus Clinical Innovations' specialty focus.
• CONMED Corporation: CONMED is a medical technology company with products across general surgery, OB/GYN, and gastroenterology — directly overlapping with Laborie's specialty verticals. Broad incumbent with comparable product categories and similar customer base in hospital surgical specialties.
• Medtronic: Medtronic is a global medical device leader with women's health and pelvic health product lines. Competes broadly in hospital medical devices and serves OB/GYN customers, providing scale advantages in contracting and distribution versus specialty peers.

Direct peers

• CooperSurgical: CooperSurgical is the women's health and fertility medical device arm of CooperCompanies, directly competing in OB/GYN and reproductive health devices. Comparable in serving OB/GYN call points with specialty procedural devices and consumables for women's health procedures.
• Utah Medical Products: Utah Medical Products is a direct peer developing specialty medical devices for women's health, obstetrics, and neonatal care — including blood pressure monitoring, specialty delivery devices, and neonatal products. Closest publicly-traded comparable in the maternal/child health medical device niche.
• Teleflex Incorporated: Teleflex manufactures specialty medical devices including obstetric and surgical products, with comparable portfolio breadth in single-use procedural devices and exposure to OB/GYN hospital customers. Direct competitor in obstetric surgical devices.
• Cook Medical: Cook Medical manufactures specialty medical devices across women's health, obstetrics, and minimally invasive surgery. Direct peer in single-use procedural devices for OB/GYN applications, with comparable focus on specialty interventional products.

Emerging players

• Integra LifeSciences: Integra LifeSciences manufactures specialty medical devices and surgical products with overlap in women's health, surgical instruments, and tissue technologies. Comparable as a specialty-focused mid-market medical device company with hospital-focused sales motion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/clinical-innovations

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Innovations